Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration

Sahni, Jayashree; Dugel, Pravin U.; Patel, Sunil S.; Chittum, Mark E.; Berger, Brian; del Valle Rubido, Marta; Sadikhov, Shamil; Szczesny, Piotr; Schwab, Dietmar; Nogoceke, Everson; Weikert, Robert; Fauser, Sascha

doi:10.1001/jamaophthalmol.2020.2685

Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration

This phase 2 randomized clinical trial assesses the efficacy and safety of different doses and regimens of faricimab vs ranibizumab in patients with neovascular age-related macular degeneration.